Tag: CX 2023
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82....
Nectero EAST® System touted as potential “game changer” for smaller infrarenal...
“A truly novel and potentially groundbreaking treatment strategy for patients with small to mid-sized infrarenal abdominal aortic aneurysms,” is how Michael R. Jaff (Boston,...
Shape memory polymer: “Another step down the road” toward active aneurysm...
“There is an increasing awareness that we need to get aneurysm sacs to regress after endovascular aneurysm repair ,” Andrew Holden (Auckland, New Zealand)...
Can sirolimus-coated balloons overcome current treatment challenges for chronic limb-threatening ischaemia...
Eric Secemsky (Boston, USA) and Edward Choke (Singapore) discuss the role of sirolimus-coated balloons in the treatment of peripheral arterial disease (PAD), particularly below...
Statins do not sway perioperative mortality in aortic repair, but confer...
Following his first-to-podium presentation on statin treatment after aortic repair at the 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK), Kevin Mani...
Venous valve technologies set to address “large unmet need worldwide”
“I see a future where this technology may be used to treat people early and avoid the devastating long term consequences of venous insufficiency”...
Balloon-expandable and self-expandable stent grafts show “similar” primary patency for BEVAR
Konstantinos Spanos (Larissa, Greece) recently shared new meta-analysis data from comparative studies evaluating balloon-expandable versus self-expandable stent grafts for branched endovascular aneurysm repair (BEVAR)....
DCBs are “first-line treatment for better outcomes” for typical vascular access...
NOTE: This video is ONLY available to watch in selected countries and geographies
Could drug-coated balloons (DCBs) be “the perfect device” for the treatment...
Study finds Serranator serration balloon safe and effective in pedal arteries
A recent study has concluded that the “novel” technique of serration angioplasty with the Serranator balloon (Cagent Vascular) for the treatment of chronic limb-threatening...
“A hugely exciting time”: Experts focus in on AI in the...
Artificial intelligence (AI) is “here to stay”. This was the closing statement from Randy Moore (Calgary, Canada), vascular surgeon and chief medical officer (CMO)...
Open and endovascular surgery recommended over ligation in ruptured extracranial carotid...
Both open and endovascular surgical approaches are likely to produce improved outcomes compared to ligation in the treatment of ruptured extracranial carotid artery aneurysms....
Vascular News 98 – June 2023 US Edition
In this issue:
Extensive coverage of CX 2023, including a full report of the BASIL-2 randomised controlled trial results
New guidelines: Chris Twine (Bristol, UK)...
Vascular News 98 – June 2023
In this issue:
Extensive coverage of CX 2023, including a full report of the BASIL-2 randomised controlled trial results
New guidelines: Chris Twine (Bristol,...
CX 2023: IN.PACT AV three-year subanalysis trial data show “durable” long-term...
The 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK) saw a first-to-podium presentation by Andrew Holden (Auckland City Hospital, Auckland, New Zealand)...
Vascular News’ top 10 most popular stories of April 2023
April's top 10 sees a product announcement from Terumo Aortic take the top spot, with highlights from the 2023 Charing Cross (CX) International Symposium...
Medical therapy improvements mean “the time has come” to reconduct prior...
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies (Imperial College London, London, UK), putting forward...
BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
Vascular community split over “death” of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—at...
Endurant stent graft proves efficacious and durable in ENGAGE 10-year data
A first-to-podium presentation at the 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK) saw Hence Verhagen (Erasmus Medical Center, Rotterdam, The Netherlands)...
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium...
BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
Vascular News – CX Special Edition 2023 US
In this issue:
What to expect from CX 2023
A year in profiles: Alexander Zimmermann, Joseph Coselli, Markus Steinbauer and Jon Boyle
Medical devices: Key...
Vascular News – CX Special Edition 2023
In this issue:
What to expect from CX 2023
A year in profiles: Alexander Zimmermann, Joseph Coselli, Markus Steinbauer and Jon Boyle
Medical devices: Key...
CX 2023 seeks consensus in “rapidly” progressing venous field
The CX 2023 Venous & Lymphatic programme is set to be a “highlight” of this year’s meeting, CX co-chair and executive board member Erin...
CX 2023 highlight: The BASIL-2 trial
Data and discussion on revascularisation treatment strategies for patients with chronic limb-threatening ischaemia (CLTI) will take centre stage at the CX 2023 Consensus update,...
Vascular News 97 – February 2023 US Edition
In this issue:
CX 2023 preview: Headline peripheral session to spotlight audience view on new BASIL-2 findings
Journal highlight: Individual patient data meta-analysis probes safety...
Vascular News 97 – February 2023 OUS Edition
In this issue:
CX 2023 preview: Headline peripheral session to spotlight audience view on new BASIL-2 findings
Journal highlight: Individual patient data meta-analysis probes...
